Publication | Open Access

Choice of tumour markers in patients with neuroendocrine tumours is dependent on the histological grade. A marker study of Chromogranin A, Neuron specific enolase, Progastrin-releasing peptide and cytokeratin fragments

Tumor BiologyNeuro-oncologyTumor InnervationMedicinePharmacologyNeuroendocrine DisorderPathologyTumour MarkersMarker StudyNeuroendocrine TumorsEndocrinologyOncologyGliomaCytokeratin FragmentsCancer ResearchEndocrine-related Cancer